Emergency Physician-performed Ultrasound-guided Femoral Nerve Blocks in Patients With Hip Fractures.

November 5, 2026 updated by: National Taiwan University Hospital

Ultrasound-Guided Femoral Nerve Block

In this prospective study, emergency physicians perform ultrasound-guided femoral nerve block for patients with hip fractures. We compare the effectiveness of analgesia and patient satisfaction of ultrasound-guided femoral nerve block with liberal use of the pain medicine in the emergency department. The primary outcome is the change in movement-evoked pain score from baseline to 30 minutes. The secondary outcome is patient satisfaction and adverse effects for different method of pain control.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

The aim of this study is to compare the effectiveness of ultrasound-guided femoral nerve blocks performed by emergency physicians for pain control in the emergency department with traditional pain medicine.

This study is a prospective before-and-after design. The enrollees are 20-year-old and older adult patients with hip fractures. We use numerical rating scale using a 0-10 scale to assess pain severity at the different time frame after giving pain medicine. The scale zero means "no pain" and scale 10 means "the worst pain imaginable".

The primary outcome is assessed by the reduction of pain scale which are taken on a numeric rating scale every 30 minutes before and after pain management. The secondary outcome compares complications, adverse effects and patient satisfaction for different method of pain control.

Study Type

Interventional

Enrollment (Actual)

72

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Yunlin County
      • Douliu, Yunlin County, Taiwan, 640
        • NTUH Yunlin Branch

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients older than 20-year-old with hip fractures
  • Stay in the emergency department for at lease two hours

Exclusion Criteria:

  • hemodynamic unstable
  • major trauma in addition to hip fractures
  • the use of any pain management before the arrival of emergency department
  • inability to understood the numerical rating scale after instruction
  • allergy to local anesthetics
  • coagulopathy
  • injection site infection

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Sequential Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Ultrasound-guided femoral nerve block

Patients with hip fractures had underwent Ultrasound-guided femoral nerve block performed by emergency physicians.

The local analgesia is injected and infiltrated around the femoral nerve under ultrasound guidance.

Active Comparator: The liberal use of pain medication

Patients with hip fractures had given intravenous or intramuscular opioids or NSAID at the emergency department.

Intravenous or intramuscular pain medication is given for patients with hip fracture.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in movement-evoked pain score from baseline to 30 minutes
Time Frame: Baseline and 30 minutes after analgesia

Pain during movement of the affected leg is rated on an 11-point numerical rating scale (NRS; 0 = no pain, 10 = worst pain imaginable) before analgesia (baseline) and 30 minutes after analgesia. The change from baseline is compared between the femoral nerve block group and the intravenous or intramuscular pain medication group.

Baseline and 30 minutes after analgesia

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adverse effects
Time Frame: two hours

Any adverse effects of different pain medication

two hours
Patient satisfaction
Time Frame: two hours

The difference of patient satisfaction between ultrasound-guided femoral nerve block and the liberal use of pain medication

two hours
Complications of ultrasound-guided femoral nerve block
Time Frame: two hours and one week after ultrasound-guided femoral nerve block or after hospital discharge

Any complications of ultrasound-guided femoral nerve block

two hours and one week after ultrasound-guided femoral nerve block or after hospital discharge
Change in pain score at rest and with movement
Time Frame: Baseline and 30, 60, and 120 minutes after analgesia

Pain at rest and during movement of the affected leg is rated on an 11-point numerical rating scale (NRS; 0 = no pain, 10 = worst pain imaginable). The change from baseline at each time point is compared between groups.

Baseline and 30, 60, and 120 minutes after analgesia

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 3, 2023

Primary Completion (Actual)

March 5, 2025

Study Completion (Actual)

December 30, 2025

Study Registration Dates

First Submitted

July 23, 2023

First Submitted That Met QC Criteria

July 23, 2023

First Posted (Actual)

August 1, 2023

Study Record Updates

Last Update Posted (Actual)

November 10, 2026

Last Update Submitted That Met QC Criteria

November 5, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 202211021RINB

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.